Author:
Dal-Ré R,Luque I,Torres R,Lahuerta J
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine
Reference31 articles.
1. Relling MV, Hoffman JM . Should pharmacogenomic studies be required for new drug approval? Clin Pharmacol Ther 2007; 81: 425–428.
2. SACGHS Secretary's Advisory Committee on Genetics, Health, and Society. Realizing the Promise of Pharmacogenomics: Opportunities and Challenges, May 2008 [Accessed 20 August 2008]. Available at
http://www4.od.nih.gov/oba/SACGHS/reports/SACGHS_PGx_Report.pdf
.
3. Roses AD . Pharmacogenetics in drug discovery and development: a translational perspective. Nat Rev Drug Discov 2008; 7: 807–817.
4. Ingelman-Sundberg M . Pharmacogenomic biomarkers for prediction of severe adverse drug reactions. N Engl J Med 2008; 358: 637–639.
5. European Medicines Agency. Committee for Proprietary Medicinal Products (CPMP). Position paper on terminology in pharmacogenetics. EMEA/CPMP/3070/01. London, 21 November 2002. [Accessed on 18 August 2008]. Available at
http://www.emea.europa.eu/pdfs/human/press/pp/307001en.pdf
.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献